# Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

> **NCT00675740** · PHASE4 · COMPLETED · sponsor: **University of Leipzig** · enrollment: 45 (actual)

## Conditions studied

- Impaired Glucose Tolerance

## Interventions

- **DRUG:** rosiglitazone
- **BEHAVIORAL:** physical exercise
- **OTHER:** control

## Key facts

- **NCT ID:** NCT00675740
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2010-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675740, "Physical Exercise Versus Rosiglitazone in CAD and Prediabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00675740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*